FDA’s device center detailed the next steps and expected deadlines for the implementation of a new multi-faceted national post-market surveillance system in an updated plan released April 23.
The update follows a white paper issued by CDRH last September detailing a comprehensive strategy to strengthen the system for tracking the safety and effectiveness of devices on the market...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?